Invivyd Inc. (IVVD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $171.58M
Last updated: Nov 17, 2026 at 11:05 AM ET
Invivyd Inc. (IVVD) Financials: Revenue, Profit and Cash Flow
Invivyd reported revenue of $53.43M for the fiscal year ended Dec 31, 2025, up 110.5% from the year before. That year, net income was -$52.49M with a net margin of -98.2%, operating cash flow was -$58.13M and free cash flow was -$58.29M. The quarter ended Sep 30, 2026 had revenue of $15.45M and net income of -$33.47M.
Revenue and Margins
The net margin was -98.2% in the fiscal year ended Dec 2025.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $53.43M | +110.5% | 93.0% | -104.0% | -98.2% |
| Dec 2024 | $25.38M | N/A | 93.6% | -696.8% | -669.4% |
| Dec 2023 | $0 | N/A | N/A | N/A | N/A |
| Dec 2022 | $0 | N/A | N/A | N/A | N/A |
| Dec 2021 | $0 | N/A | N/A | N/A | N/A |
| Dec 2020 | N/A | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Revenue | $53.43M | $25.38M | $0 | $0 | $0 | N/A |
| Cost of revenue | $3.75M | $1.62M | $0 | $0 | $0 | N/A |
| Gross profit | $49.68M | $23.77M | $0 | $0 | $0 | N/A |
| Research and development | $38.31M | $137.25M | $163.63M | $183.61M | $190.39M | $106.49M |
| Operating income | -$55.56M | -$176.88M | -$212.76M | -$248.03M | -$226.91M | -$111.99M |
| Net income | -$52.49M | -$169.93M | -$198.64M | -$241.32M | -$226.79M | -$111.98M |
| EBITDA | -$50.38M | -$166.81M | -$197.74M | -$242.88M | -$225.36M | -$65.33M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15.45M | $14.29M | $13.74M | $17.21M | $13.13M | $11.79M | $11.30M | $13.82M | $9.30M | $2.26M | $0 | $3.02M |
| Gross profit | $14.41M | $13.01M | $12.71M | $16.07M | $12.04M | $11.10M | $10.47M | $13.10M | $8.49M | $2.18M | $0 | $2.51M |
| Operating income | -$34.68M | -$45.82M | -$43.14M | -$12.55M | -$11.02M | -$15.06M | -$16.92M | -$19.23M | -$62.31M | -$49.25M | -$46.09M | -$76.75M |
| Net income | -$33.47M | -$44.39M | -$41.40M | -$11.07M | -$10.47M | -$14.66M | -$16.29M | -$18.44M | -$60.74M | -$47.25M | -$43.50M | -$73.65M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $1.31M by $225.38M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Total assets | $276.88M | $129.51M | $229.18M | $383.17M | $620.09M | $117.38M |
| Current assets | $247.47M | $100.68M | $224.88M | $376.92M | $616.71M | $117.38M |
| Cash and equivalents | $226.69M | $69.35M | $200.64M | $92.08M | $542.22M | $114.99M |
| Total liabilities | $35.34M | $61.98M | $51.71M | $27.20M | $62.07M | $13.08M |
| Short-term debt | $1.31M | $1.30M | $1.44M | $1.56M | N/A | N/A |
| Shareholder equity | $241.54M | $67.54M | $177.47M | $355.97M | $558.02M | -$65.25M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $183.91M | $218.88M | $241.74M | $276.88M | $139.16M | $89.14M | $103.74M | $129.51M | $161.92M | $177.35M | $215.47M | $229.18M |
| Total liabilities | $33.42M | $37.80M | $38.69M | $35.34M | $46.09M | $46.35M | $49.59M | $61.98M | $78.76M | $36.70M | $36.97M | $51.71M |
| Cash and equivalents | $126.40M | $160.08M | $184.15M | $226.69M | $84.97M | $34.91M | $48.08M | $69.35M | $106.87M | $147.88M | $189.39M | $200.64M |
| Shareholder equity | $150.48M | $181.08M | $203.05M | $241.54M | $93.07M | $42.79M | $54.15M | $67.54M | $83.16M | $140.64M | $178.50M | $177.47M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$58.13M | -$170.49M | -$173.16M | -$219.99M | -$184.74M | -$14.57M |
| Capital expenditures | $155.00K | $140.00K | $615.00K | $1.71M | $84.00K | $84.00K |
| Free cash flow | -$58.29M | -$170.63M | -$173.78M | -$221.69M | -$184.82M | -$14.65M |
| Share repurchases | N/A | N/A | $1.00K | $4.00K | $0 | N/A |
| Investing cash flow | -$155.00K | -$140.00K | $280.68M | -$230.67M | -$50.71M | -$50.71M |
| Financing cash flow | $215.63M | $39.33M | $1.04M | $506.00K | $662.68M | $129.56M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$32.11M | -$43.01M | -$41.71M | -$15.46M | -$8.25M | -$13.30M | -$21.13M | -$37.61M | -$41.07M | -$41.60M | -$50.21M | -$59.24M |
| Capital expenditures | $585.00K | $510.00K | $726.00K | $0 | $0 | $11.00K | $144.00K | $5.00K | $5.00K | $0 | $140.00K | $0 |
| Free cash flow | -$32.70M | -$43.52M | -$42.44M | -$15.46M | -$8.25M | -$13.31M | -$21.27M | -$37.62M | -$41.07M | -$41.60M | -$50.35M | -$59.24M |
Frequently Asked Questions About IVVD
What is Invivyd's annual revenue?
Invivyd reported revenue of $53.43M for the fiscal year ended Dec 31, 2025.
How fast is Invivyd's revenue growing?
Revenue was up 110.5% for the fiscal year ended Dec 31, 2025 compared with the year before.
Is Invivyd profitable?
No. Invivyd reported net income of -$52.49M for the fiscal year ended Dec 31, 2025, with a net margin of -98.2%.
How much free cash flow does IVVD generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$58.13M minus capital expenditures of $155.00K produced free cash flow of -$58.29M.
How much debt does Invivyd have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $1.31M and cash and equivalents of $226.69M.
IVVD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors